NEW YORK, Nov. 2 - Protein Design Labs has reported a narrower-than-expected third-quarter loss on a 74 percent spike in revenues, the company said.

The company, which develops humanized monoclonal antibodies, posted a net loss for the period ended Sept. 30 of $1.8 million, or 2 cents per basic and diluted share, compared with net loss of $5.1 million, or 6 cents per share, in 2000.

A consensus estimate of Wall Street analysts polled by Thomson Financial/First Call expected a loss of 5 cents per share.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

NPR reports on Human Cell Atlas Consortium's effort to catalog all the different cell types within the human body.

The Union of Concerned Scientists surveyed US government scientists about Trump Administration policies and more, Science reports.

National Geographic reports that marine mammals have lost a gene that could make them more susceptible to organophosphate damage.

In PNAS this week: history and genetic diversity of the scarlet macaw, approach for predicting human flu virus evolution, and more.